The control and KCNQ1OT1-knockdown CRC cells treated with the proteasome inhibitor, MG132, showed similar HK2 protein levels as analyzed by western blotting (Figure 4J). This evidence concerns the gene KCNQ1OT1 and colorectal carcinoma.